Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 1 - General processes for the preparation of peptides
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
10/2000
10/26/2000CA2366093A1 Combinatorial chemical library supports having indicia at coding positions and methods of use
10/25/2000EP1046652A1 Method for quantitating denatured ldls
10/25/2000EP1046421A2 Methods and reagents for very large scale immobilized polymer synthesis
10/25/2000EP0751950B1 Method for identifying members of combinatorial libraries
10/25/2000CN1057773C N-protection aspartic sweet piptide preparation method
10/24/2000US6136959 High efficiency alkaline protein extraction
10/24/2000US6136563 With defined substitutions for enhanced affinity for its receptor
10/24/2000US6136555 Purification method and apparatus
10/24/2000US6136553 Computer based method for identifying amino acid sites which affect stability of the target protein
10/24/2000US6136313 Processes and intermediates for synthetic antibody derivatives
10/24/2000US6136274 Matrices with memories in automated drug discovery and units therefor
10/24/2000US6136269 Combinatorial kit for polymer synthesis
10/24/2000CA2061569C Improved activation of recombinant proteins
10/19/2000WO2000062074A1 Use of 13c-nmr to detect binding
10/19/2000WO2000062034A2 Multistage electromagnetic separator for purifying cells, chemicals and protein structures
10/19/2000WO2000061789A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto
10/19/2000WO2000061762A1 RECOMBINANT TOXIN A/TOXIN B VACCINE AGAINST $i(CLOSTRIDIUM DIFFICILE)
10/19/2000WO2000061635A2 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-egp-2 scfv fragment
10/19/2000WO2000061633A1 Method for purifying blood coagulation factor viii and blood coagulation factor viii/von willebrand factor complex
10/19/2000WO2000061619A1 Protein/polypeptide-k obtained from momordica charantia and a process for the extraction thereof
10/19/2000WO2000061525A1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
10/19/2000WO2000061194A2 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
10/19/2000WO2000061069A2 Methods and compositions for use in the treatment of hyperlipidemia
10/19/2000WO2000036398A3 Method and devices for detecting optical properties, especially luminescence reactions and refraction behaviour of molecules which are directly or indirectly bound on a support
10/19/2000WO2000036093A3 Intein-mediated cyclization of peptides
10/19/2000WO2000031279A3 Producing antimicrobial cationic peptides as fusion proteins
10/19/2000DE19917713A1 Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik Short-chain peptide-dye conjugates as contrast agents for optical diagnostics
10/19/2000DE19915057A1 Monoklonale Antikörper gegen das humane Mcm3 Protein, Verfahren zu ihrer Herstellung und ihre Verwendung Monoclonal antibodies to human protein Mcm3, processes for their preparation and their use
10/19/2000CA2369908A1 Protein/polypeptide-k obtained from momordica charantia and a process for the extraction thereof
10/19/2000CA2369827A1 Separation of plasma components
10/19/2000CA2368490A1 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics
10/19/2000CA2366671A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto
10/19/2000CA2366543A1 Multistage electromagnetic separator for purifying cells, chemicals and protein structures
10/19/2000CA2365915A1 Recombinant toxin a/toxin b vaccine against clostridium difficile
10/18/2000EP1044716A1 Micropreparative isoelectric focussing
10/18/2000EP1044418A1 Method for providing, identifying and describing molecules capable of having a required activity, in particular in pharmacology and molecules resulting from said method
10/18/2000EP1044214A1 Method for binding albumin and means to be used in the method
10/18/2000EP0467932B1 Urokinase-type plasminogen activator receptor
10/18/2000CN1057535C Process for producing hydrophobic polypeptides proteins or peptides
10/17/2000US6133229 Stabilizing aqueous enzyme with aqueous solution comprising tris/hydroxymethyl/methyl compound, cationic polyelectrolyte, polyol, salt of calcium, magnesium and/or cobalt
10/17/2000CA2178752C N-terminally chemically modified protein compositions and methods
10/17/2000CA2163781C Method and apparatus for conducting an array of chemical reactions on a support surface
10/17/2000CA2068320C Production of recombinant human interleukin-1 inhibitor
10/12/2000WO2000060345A1 Method for screening crystallization conditions in solution crystal growth
10/12/2000WO2000059943A2 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE
10/12/2000WO2000059927A1 Purification of biological preparations
10/12/2000WO2000059925A1 A process for the production of glutamine derivatives and glutamine containing molecules
10/12/2000WO2000035940A3 Method and devices for applying substances to a support, especially monomers for the combinatorial synthesis of molecule libraries
10/12/2000CA2369935A1 Method for screening crystallization conditions in solution crystal growth
10/12/2000CA2365513A1 Purification of biological preparations
10/11/2000EP1042479A1 A process for preparing human proinsulin
10/11/2000EP1042443A1 Granule with hydrated barrier material
10/11/2000EP1042436A2 Method of preparing lipoproteins, lipoaminoacids, lipid esters, and glucolipids from chlorinated olive oil and/or its constituents
10/11/2000EP1042358A1 Free solution ligand interaction molecular separation method
10/11/2000EP1042357A1 Process for the preparation of solid polymer composites
10/11/2000EP1042337A2 Oligonucleotide synthesis using high boiling point solvents
10/11/2000EP1042060A1 Method and apparatus for chemical synthesis
10/11/2000CN1057306C New polypeptide compound and process for preparation thereof
10/10/2000US6130202 Antiviral methods
10/10/2000CA2030516C Parathyroid hypertensive factor
10/05/2000WO2000058493A1 Method for synthesis of polypeptides in cell-free systems
10/05/2000WO2000058342A1 Process for partitioning of proteins
10/05/2000WO2000018881A9 Intein mediated peptide ligation
10/05/2000CA2367826A1 Process for partitioning of proteins
10/04/2000EP1041149A2 Vaccine and antitoxin for treatment and prevention of C. difficile disease
10/04/2000EP1041082A1 Process of peptidic synthesis starting from N-carboxyanhydride amino acids
10/04/2000EP1040151A1 Heterofunctionalized star-shaped poly(ethylene glycols) for protein modification
10/04/2000EP1039922A1 Improved interferon polymer conjugates
10/04/2000EP1039921A1 Substantially pure histidine-linked protein polymer conjugates
10/04/2000EP1039873A1 Keratin-based hydrogel for biomedical applications and method of production
10/04/2000EP0479870B1 A mutated subtilisin protease
10/04/2000CN1268905A Laminated assembly for active bioelectronic device
10/04/2000CN1268516A Preparation method of phycocyanin
10/04/2000CN1057098C Glucagon-like peptide and insulinotropin derivatives
10/04/2000CN1057095C Novel peptides, prepn. and use thereof
10/04/2000CN1057013C Novel 1 L-2 receptor-specific human immunoglobins
10/03/2000US6128582 Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them
10/03/2000US6127526 Protein purification by Protein A chromatography
10/03/2000US6127515 Aminomethylated polystyrene resin amidated with 2-(4-hydroxy-3-nitrobenzoyl)benzoic acid or 4-hydroxypyridine-2-carboxylic acid being o-esterified with an organic acid which cleaves upon reacting with an amine to form desired amide product
10/03/2000US6127336 Antibacterial and antifungal peptide
10/03/2000US6127335 Cyclic adhesion inhibitors
10/03/2000US6127190 Method for producing combinatorial libraries having a predetermined frequency of each species of test compound
10/03/2000US6127169 Non-agglutinating β-galactoside binding protein and its encoding nucleic acid
10/03/2000US6127151 Antigenic preparations and the isolation of such preparations
10/03/2000US6127150 Vector for the efficient expression and isolation of heterologous proteins
10/03/2000US6127148 Isolation and production of a cyclophilin-like protein endogenous to brugia malayi
10/03/2000US6127143 Preparation of purified and biocompatible collagen using two proteolytic enzyme treatments and a reducing agent
10/03/2000US6127134 Difference gel electrophoresis using matched multiple dyes
10/03/2000US6127127 Contacting nonconductive self-assembled monolayer on electrode with sample containing label-bearing target forming target complex, contacting with transition metal complex to oxidize target, detecting the oxidation-reduction reaction
10/03/2000US6126918 Screening assays to identify therapeutic agents for amyloidosis
10/03/2000CA2079171C Cyclohexapeptidyl propanolamine compounds
10/03/2000CA2031484C Reaction medium and peptides solubilizer and synthesis process therefor
10/03/2000CA2000342C Novel peptidase inhibitors
10/03/2000CA1341106C Conformationally stabilized cell adhesion peptides
09/2000
09/28/2000WO2000057183A1 Protein isolation and analysis
09/28/2000WO2000056790A1 Amino group containing support matrices, their use and manufacture
09/28/2000WO2000009464A9 Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules
09/28/2000DE19911771A1 Neue LHRH-Antagonisten mit verbesserten Löslichkeitseigenschaften New LHRH antagonists with improved solubility
09/27/2000EP1038881A2 Process for the separation of glycosylated and non-glycosylated proteins
09/27/2000EP1037940A1 Block polymer processing for mesostructured inorganic oxide materials
1 ... 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 ... 518